• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: W.L. GORE & ASSOCIATES GORE-TEX® VASCULAR GRAFT; PROSTHESIS, VASCULAR GRAFT

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

W.L. GORE & ASSOCIATES GORE-TEX® VASCULAR GRAFT; PROSTHESIS, VASCULAR GRAFT Back to Search Results
Catalog Number RRT07070080L
Device Problem Adverse Event Without Identified Device or Use Problem (2993)
Patient Problems Unspecified Infection (1930); Staphylococcus Aureus (2058)
Event Date 11/04/2016
Event Type  Injury  
Manufacturer Narrative
(b)(4).Further investigation is being conducted and the information will be included in the final report.
 
Event Description
The patient presented with a left limb claudication where a gore-tex® vascular graft was implanted as a femoropopliteal bypass on (b)(6) 2016.On (b)(6) 2016, after about 37 days, the gore-tex® vascular graft was explanted due to staphylococcus aureus and streptococcus pyogenes infections.The patient is doing well following the procedure.The clinical history of the patient notes a left maxillary sinus tumor treated with surgery on (b)(6) 2016, and chemotherapy.
 
Manufacturer Narrative
The review of the sterilization records verified that this lot met all pre-release specifications.The gore-tex® vascular graft was returned to (b)(4), independent laboratory, for investigation.Submitted in formalin was a gore-tex® vascular graft ¿ thin-walled removable ringed fragment.The scope and results of the investigation were summarized and a report was submitted to w.L.Gore & associates.An explant investigator (ei) at w.L.Gore & associates reviewed the report.The following is a summary of the ei observations: tissue present: yes.Graft fragment appears to be have mutifocal areas of glossy pink tissue adhered to the ablumen.Graft material color transitions from pink to light tan.Complete fixation of the specimen does not appear to have been achieved.Dr.Delay reported a significant amount of povidone-iodine was used during the explant which may lend to the device discoloration.Luminal tissue deposition cannot be determined via mode of analysis.From gross images the graft fragment appears to have been transected at both poles.One pole has a green suture ligation present which was likely placed during explant procedure for device removal.The graft appears to have an irregular diameter at multiple points; the cause cannot be determined via images and analysis provided.Metal surgical instruments were used during the evaluation of the returned specimen, as is evident from the photographs in the report.Request for additional analysis: no.Reason: material disruptions are consistent with surgical instruments used during the explant process.Based on review of the report in conjunction with the conclusion of the (b)(4) investigators, no additional analysis is requested.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
GORE-TEX® VASCULAR GRAFT
Type of Device
PROSTHESIS, VASCULAR GRAFT
Manufacturer (Section D)
W.L. GORE & ASSOCIATES
flagstaff AZ
Manufacturer (Section G)
MEDICAL WEST B/P
1505 n. fourth street
flagstaff AZ 86004
Manufacturer Contact
barbara ulrich
1500 n. 4th street
flagstaff, AZ 
9285263030
MDR Report Key6408768
MDR Text Key70060791
Report Number2017233-2017-00127
Device Sequence Number1
Product Code DSY
Combination Product (y/n)N
Reporter Country CodeFR
PMA/PMN Number
K880167
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type other
Reporter Occupation Physician
Type of Report Initial,Followup
Report Date 04/10/2017
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Health Professional
Device Expiration Date01/19/2021
Device Catalogue NumberRRT07070080L
Device Lot Number14677872
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Initial Date Manufacturer Received Not provided
Initial Date FDA Received03/16/2017
Supplement Dates Manufacturer ReceivedNot provided
Supplement Dates FDA Received04/28/2017
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Date Device Manufactured01/21/2016
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Patient Outcome(s) Required Intervention;
Patient Age59 YR
Patient Weight61
-
-